Criticism of new German chronic disease management is unfair
- 26 October 2002
- Vol. 325 (7370) , 971
- https://doi.org/10.1136/bmj.325.7370.971
Abstract
EDITOR—Tuffs' news item on the new chronic disease management programmes in Germany is misleading.1 The new programmes have arisen from economic analysis showing the importance of ensuring that health insurance funds should not continue to be penalised financially when they have large numbers of patients with chronic diseases. The economic rationale for these programmes is not simply to fund deficits. There will be no extra money put into the system. Instead the existing risk adjustment strategy will take the higher costs for patients with chronic …Keywords
This publication has 2 references indexed in Scilit:
- Chronic disease management programmes are criticised by doctorsBMJ, 2002
- Aspirin shown to reduce risk of pancreatic cancerPublished by BMJ ,2002